JP2009517468A - 経皮吸収治療システム - Google Patents
経皮吸収治療システム Download PDFInfo
- Publication number
- JP2009517468A JP2009517468A JP2008543278A JP2008543278A JP2009517468A JP 2009517468 A JP2009517468 A JP 2009517468A JP 2008543278 A JP2008543278 A JP 2008543278A JP 2008543278 A JP2008543278 A JP 2008543278A JP 2009517468 A JP2009517468 A JP 2009517468A
- Authority
- JP
- Japan
- Prior art keywords
- tts
- active ingredient
- rivastigmine
- treatment
- layer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
- A61K9/7061—Polyacrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Dermatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US74151105P | 2005-12-01 | 2005-12-01 | |
| PCT/US2006/039557 WO2007064407A1 (en) | 2005-12-01 | 2006-10-10 | Transdermal therapeutic system |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013107198A Division JP5938612B2 (ja) | 2005-12-01 | 2013-05-21 | 経皮吸収治療システム |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009517468A true JP2009517468A (ja) | 2009-04-30 |
| JP2009517468A5 JP2009517468A5 (cg-RX-API-DMAC7.html) | 2009-11-26 |
Family
ID=37716856
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008543278A Withdrawn JP2009517468A (ja) | 2005-12-01 | 2006-10-10 | 経皮吸収治療システム |
| JP2013107198A Active JP5938612B2 (ja) | 2005-12-01 | 2013-05-21 | 経皮吸収治療システム |
| JP2015233544A Active JP6298034B2 (ja) | 2005-12-01 | 2015-11-30 | 経皮吸収治療システム |
Family Applications After (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013107198A Active JP5938612B2 (ja) | 2005-12-01 | 2013-05-21 | 経皮吸収治療システム |
| JP2015233544A Active JP6298034B2 (ja) | 2005-12-01 | 2015-11-30 | 経皮吸収治療システム |
Country Status (31)
Cited By (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5093545B1 (ja) * | 2012-02-28 | 2012-12-12 | ニチバン株式会社 | 貼付剤 |
| JP2013515025A (ja) * | 2009-12-22 | 2013-05-02 | アシノ アーゲー | リバスチグミンまたはその誘導体を投与するための経皮治療システム |
| JP2013177419A (ja) * | 2005-12-01 | 2013-09-09 | Novartis Ag | 経皮吸収治療システム |
| WO2013187451A1 (ja) * | 2012-06-12 | 2013-12-19 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| JP2014503523A (ja) * | 2010-12-14 | 2014-02-13 | アシノ アーゲー | 有効成分を投与するための経皮治療システム |
| WO2014034939A1 (ja) | 2012-09-03 | 2014-03-06 | ニプロパッチ株式会社 | 貼付剤 |
| WO2014051128A1 (ja) * | 2012-09-28 | 2014-04-03 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| JP2014508728A (ja) * | 2010-12-24 | 2014-04-10 | サムヤン バイオファーマシューティカルズ コーポレイション | リバスティグミンを含有する経皮吸収製剤 |
| JP2014513719A (ja) * | 2011-05-20 | 2014-06-05 | エスケー ケミカルズ カンパニー,リミテッド | リバスティグミン含有パッチ |
| WO2015087927A1 (ja) | 2013-12-12 | 2015-06-18 | 久光製薬株式会社 | カバー材付き貼付剤及びカバー材付き貼付剤キット |
| JP2015535827A (ja) * | 2012-09-21 | 2015-12-17 | マイラン・インコーポレーテッド | 経皮ドラッグデリバリーデバイス |
| JP2016522792A (ja) * | 2013-03-15 | 2016-08-04 | エヌエーエル ファーマスーティカル グループ リミテッド | リバスチグミンを含む、経皮薬物送達システム |
| US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| KR20190039950A (ko) | 2016-08-22 | 2019-04-16 | 규큐 야쿠힝 고교 가부시키가이샤 | 첩부제 |
| US10308408B2 (en) | 2014-05-15 | 2019-06-04 | Nichiban Co., Ltd. | Packaging for adhesive patch containing rivastigmine |
| JP2020523405A (ja) * | 2017-05-19 | 2020-08-06 | ボヒュン ファーマーシューティカル カンパニー リミテッド | ドネペジルを含有するマイクロニードル経皮パッチ |
| JP2021527695A (ja) * | 2018-06-19 | 2021-10-14 | エルテーエス ローマン テラピー−ジステーメ アーゲー | リバスチグミンを含有する経皮治療システム |
| US11975097B2 (en) | 2009-10-30 | 2024-05-07 | Ix Biopharma Ltd. | Fast dissolving solid dosage form |
| US12186426B2 (en) | 2009-10-30 | 2025-01-07 | Ix Biopharma Ltd. | Solid dosage form |
Families Citing this family (86)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9248104B2 (en) * | 2006-08-17 | 2016-02-02 | Core Tech Solutions, Inc. | Transdermal methods and systems for treating Alzheimer's disease |
| TWI630208B (zh) | 2008-12-08 | 2018-07-21 | 歐陸斯迪公司 | 二氫羥戊甲嗎啡 |
| GB0823554D0 (en) | 2008-12-24 | 2009-01-28 | Novartis Ag | Process for the preparation of optically active compounds using transfer hydrogenation |
| CN102803423A (zh) * | 2009-04-17 | 2012-11-28 | 3M创新有限公司 | 有机硅凝胶粘合剂构造 |
| US20100286260A1 (en) * | 2009-05-05 | 2010-11-11 | Forest Laboratories Holdings Ltd. | Milnacipran formulations |
| WO2011073362A1 (en) | 2009-12-18 | 2011-06-23 | Novartis Ag | Process for the preparation of optically active compounds using pressure hydrogenation |
| US20100178307A1 (en) * | 2010-01-13 | 2010-07-15 | Jianye Wen | Transdermal anti-dementia active agent formulations and methods for using the same |
| RU2578971C2 (ru) * | 2010-06-17 | 2016-03-27 | Лтс Ломанн Терапи-Системе Аг | Трансдермальное введение мемантина |
| DE102010024105A1 (de) * | 2010-06-17 | 2011-12-22 | Grünenthal GmbH | Transdermale Verabreichung von Memantin |
| DE102010026903A1 (de) | 2010-07-12 | 2012-01-12 | Amw Gmbh | Transdermales therapeutisches System mit Avocadoöl oder Palmöl als Hilfsstoff |
| EP2596071B1 (en) | 2010-07-21 | 2019-02-13 | 3M Innovative Properties Company | Transdermal adhesive compositions, devices, and methods |
| CA2807552A1 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| US20120046383A1 (en) * | 2010-08-19 | 2012-02-23 | Terumo Kabushiki Kaisha | Silicone rubber composition |
| EP2857499A1 (en) | 2010-10-01 | 2015-04-08 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| KR101054317B1 (ko) * | 2011-01-28 | 2011-08-08 | 신신제약 주식회사 | 리바스티그민을 함유하는 경피흡수제제 |
| KR101317158B1 (ko) * | 2011-02-18 | 2013-10-15 | 조선대학교산학협력단 | 갈란타민 또는 그의 염을 함유하는 경피흡수제제 |
| CA2831613A1 (en) | 2011-03-31 | 2012-10-04 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| KR20120130073A (ko) * | 2011-05-20 | 2012-11-28 | 에스케이케미칼주식회사 | 리바스티그민 함유 패취 |
| US9333182B2 (en) | 2011-08-31 | 2016-05-10 | Sekisui Medical Co., Ltd. | Adhesive patch |
| US9464124B2 (en) | 2011-09-12 | 2016-10-11 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| PT3682905T (pt) | 2011-10-03 | 2022-04-07 | Modernatx Inc | Nucleósidos, nucleótidos e ácidos nucleicos modificados e respetivas utilizações |
| EP2782584B1 (en) | 2011-11-23 | 2021-06-09 | TherapeuticsMD, Inc. | Natural combination hormone replacement formulations and therapies |
| US9301920B2 (en) | 2012-06-18 | 2016-04-05 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| ES2923757T3 (es) | 2011-12-16 | 2022-09-30 | Modernatx Inc | Composiciones de ARNm modificado |
| KR101399035B1 (ko) * | 2011-12-22 | 2014-05-28 | 주식회사 트랜스덤 | 리바스티그민을 함유하는 경피흡수제제 |
| DE102012000369A1 (de) | 2012-01-11 | 2013-07-11 | Alfred E. Tiefenbacher (Gmbh & Co. Kg) | Transdermales therapeutisches System mit Cholinesterase-Hemmer |
| WO2013151664A1 (en) | 2012-04-02 | 2013-10-10 | modeRNA Therapeutics | Modified polynucleotides for the production of proteins |
| WO2013142339A1 (en) | 2012-03-23 | 2013-09-26 | Novartis Ag | Transdermal therapeutic system and method |
| US9572897B2 (en) | 2012-04-02 | 2017-02-21 | Modernatx, Inc. | Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins |
| US10501512B2 (en) | 2012-04-02 | 2019-12-10 | Modernatx, Inc. | Modified polynucleotides |
| US9283287B2 (en) | 2012-04-02 | 2016-03-15 | Moderna Therapeutics, Inc. | Modified polynucleotides for the production of nuclear proteins |
| US20150051559A1 (en) * | 2012-04-05 | 2015-02-19 | Sparsha Pharma International Private Limited | Transdermal patch for treatment of dementia or alzheimer type dementia |
| US10806740B2 (en) | 2012-06-18 | 2020-10-20 | Therapeuticsmd, Inc. | Natural combination hormone replacement formulations and therapies |
| US10806697B2 (en) | 2012-12-21 | 2020-10-20 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US20130338122A1 (en) | 2012-06-18 | 2013-12-19 | Therapeuticsmd, Inc. | Transdermal hormone replacement therapies |
| US20150196640A1 (en) | 2012-06-18 | 2015-07-16 | Therapeuticsmd, Inc. | Progesterone formulations having a desirable pk profile |
| CN104582693A (zh) * | 2012-08-15 | 2015-04-29 | 道康宁公司 | 多层药物递送系统 |
| KR20140038237A (ko) * | 2012-09-20 | 2014-03-28 | 에스케이케미칼주식회사 | 리바스티그민의 안정성이 개선된 의약품 |
| TW201431570A (zh) | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
| PT2922554T (pt) | 2012-11-26 | 2022-06-28 | Modernatx Inc | Arn modificado nas porções terminais |
| US10537581B2 (en) | 2012-12-21 | 2020-01-21 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10568891B2 (en) | 2012-12-21 | 2020-02-25 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US11266661B2 (en) | 2012-12-21 | 2022-03-08 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US10471072B2 (en) | 2012-12-21 | 2019-11-12 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| US9180091B2 (en) | 2012-12-21 | 2015-11-10 | Therapeuticsmd, Inc. | Soluble estradiol capsule for vaginal insertion |
| US11246875B2 (en) | 2012-12-21 | 2022-02-15 | Therapeuticsmd, Inc. | Vaginal inserted estradiol pharmaceutical compositions and methods |
| WO2014111790A2 (en) | 2013-01-15 | 2014-07-24 | Zydus Technologies Limited | Stable transdermal pharmaceutical drug delivery system comprising rivastigmine |
| RU2560668C2 (ru) * | 2013-03-04 | 2015-08-20 | Общество с ограниченной ответственностью Научно-производственное объединение "Клеточные технологии" | Трансдермальный седативный фармацевтический гель для лечения психоэмоциальных расстройств |
| AR095259A1 (es) * | 2013-03-15 | 2015-09-30 | Noven Pharma | Composiciones y métodos para la administración transdérmica de fármacos de amina terciaria |
| US8980864B2 (en) | 2013-03-15 | 2015-03-17 | Moderna Therapeutics, Inc. | Compositions and methods of altering cholesterol levels |
| GB201309654D0 (en) | 2013-05-30 | 2013-07-17 | Euro Celtique Sa | Method |
| TWI745577B (zh) * | 2013-06-12 | 2021-11-11 | 日商Km特蘭斯達股份有限公司 | 經皮吸收製劑 |
| EP3040068B1 (en) | 2013-06-12 | 2021-08-18 | KM Transderm Ltd. | Adhesive sheet for application to the skin, and percutaneous absorption preparation using same |
| CN105358139B (zh) | 2013-07-03 | 2020-10-16 | Lts罗曼治疗方法有限公司 | 具有电子元件的经皮治疗系统 |
| KR20160067219A (ko) | 2013-10-03 | 2016-06-13 | 모더나 세라퓨틱스, 인코포레이티드 | 저밀도 지단백질 수용체를 암호화하는 폴리뉴클레오타이드 |
| TWI709417B (zh) | 2013-10-07 | 2020-11-11 | 美商帝國製藥美國股份有限公司 | 使用右美托咪啶經皮組成物用於治療注意力不足過動症、焦慮及失眠的方法及組成物 |
| RU2646512C2 (ru) | 2013-10-07 | 2018-03-05 | ТЕЙКОКУ ФАРМА ЮЭсЭй, ИНК. | Устройства для трансдермальной доставки дексмедетомидина и способы их применения |
| KR101891185B1 (ko) | 2013-10-07 | 2018-08-24 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 비진정량의 덱스메데토미딘의 경피 전달을 위한 방법 및 조성물 |
| CN103877063A (zh) * | 2014-03-24 | 2014-06-25 | 张绪伟 | 一种重酒石酸卡巴拉汀胶囊及其制备方法 |
| US9949935B2 (en) | 2014-04-08 | 2018-04-24 | Teikoku Pharma Usa, Inc. | Rivastigmine transdermal compositions and methods of using the same |
| JP6573913B2 (ja) | 2014-05-20 | 2019-09-11 | エルテーエス ローマン テラピー−ジステーメ アーゲー | ロチゴチンを含む経皮送達システム |
| ES2954087T3 (es) | 2014-05-20 | 2023-11-20 | Lts Lohmann Therapie Systeme Ag | Sistema de administración transdérmica que incluye un mediador de interfase |
| CN106456567A (zh) | 2014-05-20 | 2017-02-22 | Lts勒曼治疗系统股份公司 | 在经皮递送系统中调节活性剂释放的方法 |
| AR100562A1 (es) | 2014-05-22 | 2016-10-12 | Therapeuticsmd Inc | Composición farmacéutica de estradiol y progesterona para terapia de reemplazo hormonal |
| CN204119542U (zh) | 2014-09-24 | 2015-01-21 | 上海荣威塑胶工业有限公司 | 一种ptc加热器 |
| CN104523656A (zh) * | 2014-11-20 | 2015-04-22 | 美吉斯制药(厦门)有限公司 | 一种卡巴拉汀缓释透皮贴剂及其制备方法 |
| EP4483902A3 (en) | 2014-12-05 | 2025-04-16 | KM Transderm Ltd. | Adhesive sheet for attachment to skin and percutaneous absorption preparation using same |
| DE102015107743A1 (de) | 2015-05-18 | 2016-11-24 | Bsn Medical Gmbh | Silikongelbeschichtete adhäsive Schichtstruktur |
| US10328087B2 (en) | 2015-07-23 | 2019-06-25 | Therapeuticsmd, Inc. | Formulations for solubilizing hormones |
| WO2017173044A1 (en) | 2016-04-01 | 2017-10-05 | Therapeuticsmd Inc. | Steroid hormone compositions in medium chain oils |
| KR20180126582A (ko) | 2016-04-01 | 2018-11-27 | 쎄러퓨틱스엠디, 인코퍼레이티드 | 스테로이드 호르몬 약제학적 조성물 |
| US9980921B2 (en) * | 2016-06-30 | 2018-05-29 | Taho Pharmaceuticals Ltd. | Transdermal delivery system containing methylphenidate or its salts and methods thereof |
| KR20190060007A (ko) | 2016-10-31 | 2019-05-31 | 테이코쿠 팔마 유에스에이, 인코포레이티드 | 덱스메데토미딘 경피 전달 장치를 이용한 통증을 관리하는 방법 |
| CN110087641B (zh) | 2016-12-20 | 2024-03-12 | 罗曼治疗系统股份公司 | 含有阿塞那平和聚硅氧烷或聚异丁烯的透皮治疗系统 |
| PL3338768T3 (pl) | 2016-12-20 | 2020-05-18 | Lts Lohmann Therapie-Systeme Ag | Transdermalny system terapeutyczny zawierający asenapinę |
| EP3678647A1 (en) | 2017-09-05 | 2020-07-15 | LTS Lohmann Therapie-Systeme AG | Transdermal therapeutic system for the transdermal administration of rivastigmine |
| WO2019175101A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| BR112020018300A2 (pt) * | 2018-03-13 | 2020-12-22 | Lts Lohmann Therapie-Systeme Ag | Sistema terapêutico transdérmico compreendendo um polímero híbrido de silicone e acrílico |
| CA3092752A1 (en) * | 2018-03-13 | 2019-09-19 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising a silicone acrylic hybrid polymer |
| BR112020026099A2 (pt) | 2018-06-20 | 2021-03-23 | Lts Lohmann Therapie-Systeme Ag | sistema terapêutico transdérmico que contém asenapina |
| CN118806732A (zh) | 2018-06-20 | 2024-10-22 | 罗曼治疗系统股份公司 | 含有阿塞那平的透皮治疗系统 |
| CN113382724B (zh) | 2019-01-31 | 2024-09-27 | 久光制药株式会社 | 贴剂 |
| CN114025748A (zh) * | 2019-07-09 | 2022-02-08 | 罗曼治疗系统股份公司 | 包括包含含硅酮聚合物的含活性剂层和包含硅酮凝胶粘合剂的皮肤接触层的透皮治疗系统 |
| US20220241216A1 (en) * | 2019-07-09 | 2022-08-04 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system comprising an active agent-containing layer comprising an acrylic polymer and a skin contact layer comprising a silicone gel adhesive |
| CN113616625B (zh) * | 2021-08-26 | 2023-05-30 | 大连科翔科技开发有限公司 | 一种卡巴拉汀的长效透皮贴剂 |
| WO2024160939A1 (en) * | 2023-02-01 | 2024-08-08 | Lts Lohmann Therapie-Systeme Ag | Transdermal therapeutic system for the transdermal administration of huperzine a |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002500178A (ja) * | 1998-01-12 | 2002-01-08 | ノバルティス ファーマ アクチエンゲゼルシャフト | 抗酸化剤含有tts |
| JP2002542277A (ja) * | 1999-04-22 | 2002-12-10 | エルティエス ローマン テラピー−ズュステーメ アーゲー | 中和されたアクリル性粘着パッチを備えた経皮治療システム |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NL195004C (nl) | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| US5059426A (en) * | 1989-03-22 | 1991-10-22 | Cygnus Therapeutic Systems | Skin permeation enhancer compositions, and methods and transdermal systems associated therewith |
| US5252335A (en) * | 1989-07-12 | 1993-10-12 | Cygnus Therapeutic Systems | Transdermal administration of lisuride |
| DE4301783C1 (de) * | 1993-01-23 | 1994-02-03 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Galanthamin als wirksamem Bestandteil |
| US6316023B1 (en) | 1998-01-12 | 2001-11-13 | Novartis Ag | TTS containing an antioxidant |
| DE19922662C1 (de) * | 1999-05-18 | 2000-12-28 | Sanol Arznei Schwarz Gmbh | Transdermales therapeutisches System (TTS) Tolterodin enthaltend |
| WO2001032115A1 (en) * | 1999-11-04 | 2001-05-10 | Xel Herbaceuticals | Transdermal administration of huperzine |
| US20020192243A1 (en) * | 1999-12-16 | 2002-12-19 | Tsung-Min Hsu | Transdermal and topical administration of drugs for the treatment of Alzheimer's disease using basic enhancers |
| US20030104041A1 (en) * | 1999-12-16 | 2003-06-05 | Tsung-Min Hsu | Transdermal and topical administration of drugs using basic permeation enhancers |
| DE10033853A1 (de) * | 2000-07-12 | 2002-01-31 | Hexal Ag | Transdermales therapeutisches System mit hochdispersem Siliziumdioxid |
| WO2002045701A2 (en) * | 2000-12-05 | 2002-06-13 | Noven Pharmaceuticals, Inc. | Crystallization inhibition of drugs in transdermal drug delivery systems |
| DE10103860B4 (de) | 2001-01-30 | 2004-12-23 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System für die Verabreichung carboxylgruppenhaltiger, nichtsteroidaler Antiphlogistika, sowie Verfahren zu seiner Herstellung |
| CA2459146A1 (en) * | 2001-08-30 | 2003-03-13 | Ortho-Mcneil Pharmaceutical, Inc. | Treatment of dementia and memory disorders with anticonvulsants and acetylcholinesterase inhibitors |
| DE10159745A1 (de) * | 2001-12-05 | 2003-07-03 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit verbessertem Langzeittragekomfort |
| EP1509232B1 (en) * | 2002-05-31 | 2008-11-19 | H. Lundbeck A/S | A combination of an nmda-antagonist and acetylcholine esterase inhibitors for the treatment of alzheimer's disease |
| CN100339070C (zh) * | 2002-10-24 | 2007-09-26 | 莫茨药物股份两合公司 | 包含1-氨基环己烷衍生物类和乙酰胆碱酯酶抑制剂类的药物组合物 |
| JP2007523121A (ja) | 2004-02-19 | 2007-08-16 | ノバルティス アクチエンゲゼルシャフト | 血管性鬱病の処置のためのコリンエステラーゼ阻害剤の使用 |
| TWI389709B (zh) * | 2005-12-01 | 2013-03-21 | Novartis Ag | 經皮治療系統 |
| EP2596889B1 (en) * | 2011-11-23 | 2017-04-26 | Sandvik Intellectual Property AB | A cutting insert and a milling tool |
-
2006
- 2006-10-05 TW TW095137245A patent/TWI389709B/zh not_active IP Right Cessation
- 2006-10-10 PT PT101790855T patent/PT2292219E/pt unknown
- 2006-10-10 RU RU2008126459/15A patent/RU2450805C2/ru active
- 2006-10-10 KR KR1020147010333A patent/KR20140072108A/ko not_active Withdrawn
- 2006-10-10 KR KR1020137031255A patent/KR20130143729A/ko not_active Ceased
- 2006-10-10 ES ES10179085T patent/ES2414455T3/es active Active
- 2006-10-10 SI SI200631618T patent/SI2292219T1/sl unknown
- 2006-10-10 KR KR1020087013112A patent/KR20080071581A/ko not_active Ceased
- 2006-10-10 MY MYPI20081730 patent/MY151020A/en unknown
- 2006-10-10 CA CA002563110A patent/CA2563110A1/en active Pending
- 2006-10-10 US US11/539,979 patent/US20070128263A1/en not_active Abandoned
- 2006-10-10 EP EP06816633A patent/EP1959937A1/en not_active Withdrawn
- 2006-10-10 EP EP10179085.5A patent/EP2292219B9/en not_active Revoked
- 2006-10-10 KR KR1020177006994A patent/KR20170033449A/ko not_active Ceased
- 2006-10-10 KR KR1020217001087A patent/KR20210008440A/ko not_active Ceased
- 2006-10-10 KR KR1020187012945A patent/KR20180050441A/ko not_active Ceased
- 2006-10-10 BR BRPI0619758-2A patent/BRPI0619758A2/pt not_active Application Discontinuation
- 2006-10-10 DE DE14163637.3T patent/DE14163637T1/de active Pending
- 2006-10-10 EP EP17155300.1A patent/EP3235495A1/en not_active Ceased
- 2006-10-10 PL PL10179085T patent/PL2292219T4/pl unknown
- 2006-10-10 NZ NZ568273A patent/NZ568273A/en not_active IP Right Cessation
- 2006-10-10 CN CN2011100034841A patent/CN102048713A/zh active Pending
- 2006-10-10 JP JP2008543278A patent/JP2009517468A/ja not_active Withdrawn
- 2006-10-10 KR KR1020227039266A patent/KR20220156666A/ko not_active Ceased
- 2006-10-10 BR BRBR122013013162-0A patent/BR122013013162A2/pt not_active Application Discontinuation
- 2006-10-10 EP EP10179084A patent/EP2286802A1/en not_active Withdrawn
- 2006-10-10 EP EP20140163637 patent/EP2786748A1/en not_active Ceased
- 2006-10-10 SG SG2014014989A patent/SG2014014989A/en unknown
- 2006-10-10 DK DK10179085.5T patent/DK2292219T3/da active
- 2006-10-10 DE DE202006021172U patent/DE202006021172U1/de not_active Ceased
- 2006-10-10 AU AU2006320919A patent/AU2006320919B2/en not_active Ceased
- 2006-10-10 CN CNA2006800434220A patent/CN101312717A/zh active Pending
- 2006-10-10 AR ARP060104447A patent/AR057152A1/es not_active Application Discontinuation
- 2006-10-10 WO PCT/US2006/039557 patent/WO2007064407A1/en not_active Ceased
-
2008
- 2008-05-07 ZA ZA200803882A patent/ZA200803882B/xx unknown
- 2008-05-07 IL IL191311A patent/IL191311A/en active IP Right Grant
- 2008-05-20 MY MYPI2013003893A patent/MY162986A/en unknown
- 2008-05-26 EC EC2008008469A patent/ECSP088469A/es unknown
- 2008-05-28 GT GT200800075A patent/GT200800075A/es unknown
- 2008-05-30 TN TNP2008000238A patent/TNSN08238A1/en unknown
- 2008-06-02 MA MA30991A patent/MA30022B1/fr unknown
- 2008-06-18 NO NO20082753A patent/NO20082753L/no unknown
- 2008-10-16 AT AT0059308U patent/AT11185U1/de not_active IP Right Cessation
-
2013
- 2013-01-31 DK DKBA201300014U patent/DK201300014U3/da not_active IP Right Cessation
- 2013-01-31 DK DK201300015U patent/DK201300015Y4/da not_active IP Right Cessation
- 2013-04-12 DK DKBA201300059U patent/DK201300059U3/da not_active IP Right Cessation
- 2013-04-19 PH PH12013500771A patent/PH12013500771A1/en unknown
- 2013-04-19 PH PH12013500772A patent/PH12013500772B1/en unknown
- 2013-05-21 JP JP2013107198A patent/JP5938612B2/ja active Active
- 2013-05-31 US US13/906,922 patent/US20130266633A1/en not_active Abandoned
- 2013-06-10 FI FIU20134135U patent/FI10268U1/fi not_active IP Right Cessation
-
2014
- 2014-01-21 US US14/159,609 patent/US20140134230A1/en not_active Abandoned
- 2014-07-24 AR ARP140102752A patent/AR097045A2/es not_active Application Discontinuation
- 2014-08-25 IL IL234291A patent/IL234291A/en active IP Right Grant
- 2014-08-28 IL IL234364A patent/IL234364A/en active IP Right Grant
-
2015
- 2015-11-30 JP JP2015233544A patent/JP6298034B2/ja active Active
-
2016
- 2016-10-07 DK DKBA201600113U patent/DK201600113Y4/da not_active IP Right Cessation
-
2017
- 2017-02-23 IL IL250734A patent/IL250734A0/en unknown
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2002500178A (ja) * | 1998-01-12 | 2002-01-08 | ノバルティス ファーマ アクチエンゲゼルシャフト | 抗酸化剤含有tts |
| JP2002542277A (ja) * | 1999-04-22 | 2002-12-10 | エルティエス ローマン テラピー−ズュステーメ アーゲー | 中和されたアクリル性粘着パッチを備えた経皮治療システム |
Cited By (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013177419A (ja) * | 2005-12-01 | 2013-09-09 | Novartis Ag | 経皮吸収治療システム |
| US11975097B2 (en) | 2009-10-30 | 2024-05-07 | Ix Biopharma Ltd. | Fast dissolving solid dosage form |
| US12186426B2 (en) | 2009-10-30 | 2025-01-07 | Ix Biopharma Ltd. | Solid dosage form |
| JP2013515025A (ja) * | 2009-12-22 | 2013-05-02 | アシノ アーゲー | リバスチグミンまたはその誘導体を投与するための経皮治療システム |
| US10076502B2 (en) | 2009-12-22 | 2018-09-18 | Luye Pharma Ag | Transdermal therapeutic system for administering rivastigmine or derivatives thereof |
| JP2014503523A (ja) * | 2010-12-14 | 2014-02-13 | アシノ アーゲー | 有効成分を投与するための経皮治療システム |
| JP2014508728A (ja) * | 2010-12-24 | 2014-04-10 | サムヤン バイオファーマシューティカルズ コーポレイション | リバスティグミンを含有する経皮吸収製剤 |
| JP2014513719A (ja) * | 2011-05-20 | 2014-06-05 | エスケー ケミカルズ カンパニー,リミテッド | リバスティグミン含有パッチ |
| US9238012B2 (en) | 2012-02-28 | 2016-01-19 | Nichiban Co., Ltd. | Transdermal patch |
| WO2013128562A1 (ja) | 2012-02-28 | 2013-09-06 | ニチバン株式会社 | 貼付剤 |
| JP5093545B1 (ja) * | 2012-02-28 | 2012-12-12 | ニチバン株式会社 | 貼付剤 |
| US8871245B2 (en) | 2012-02-28 | 2014-10-28 | Nichiban Co., Ltd. | Transdermal patch |
| WO2013187451A1 (ja) * | 2012-06-12 | 2013-12-19 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| JPWO2013187451A1 (ja) * | 2012-06-12 | 2016-02-08 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| US10758494B2 (en) | 2012-06-12 | 2020-09-01 | KM Transderm Ltd. | Rivastigmine-containing adhesive patch |
| JP2017137363A (ja) * | 2012-06-12 | 2017-08-10 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| WO2014034939A1 (ja) | 2012-09-03 | 2014-03-06 | ニプロパッチ株式会社 | 貼付剤 |
| JP2015535827A (ja) * | 2012-09-21 | 2015-12-17 | マイラン・インコーポレーテッド | 経皮ドラッグデリバリーデバイス |
| WO2014051128A1 (ja) * | 2012-09-28 | 2014-04-03 | 株式会社 ケイ・エム トランスダーム | 貼付剤 |
| US9895320B2 (en) | 2012-09-28 | 2018-02-20 | KM Transderm Ltd. | Transdermal patch with different viscosity hydrocarbon oils in the drug layer and the adhesive layer |
| JP2016522792A (ja) * | 2013-03-15 | 2016-08-04 | エヌエーエル ファーマスーティカル グループ リミテッド | リバスチグミンを含む、経皮薬物送達システム |
| KR20160096155A (ko) | 2013-12-12 | 2016-08-12 | 히사미쓰 세이야꾸 가부시키가이샤 | 커버재가 부착된 첩부제 및 커버재가 부착된 첩부제 키트 |
| WO2015087927A1 (ja) | 2013-12-12 | 2015-06-18 | 久光製薬株式会社 | カバー材付き貼付剤及びカバー材付き貼付剤キット |
| US10308408B2 (en) | 2014-05-15 | 2019-06-04 | Nichiban Co., Ltd. | Packaging for adhesive patch containing rivastigmine |
| KR20190039950A (ko) | 2016-08-22 | 2019-04-16 | 규큐 야쿠힝 고교 가부시키가이샤 | 첩부제 |
| JP2020523405A (ja) * | 2017-05-19 | 2020-08-06 | ボヒュン ファーマーシューティカル カンパニー リミテッド | ドネペジルを含有するマイクロニードル経皮パッチ |
| JP7090299B2 (ja) | 2017-05-19 | 2022-06-24 | ボヒュン ファーマーシューティカル カンパニー リミテッド | ドネペジルを含有するマイクロニードル経皮パッチ |
| JP2021527695A (ja) * | 2018-06-19 | 2021-10-14 | エルテーエス ローマン テラピー−ジステーメ アーゲー | リバスチグミンを含有する経皮治療システム |
| JP7402829B2 (ja) | 2018-06-19 | 2023-12-21 | エルテーエス ローマン テラピー-ジステーメ アーゲー | リバスチグミンを含有する経皮治療システム |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP5938612B2 (ja) | 経皮吸収治療システム | |
| US10729686B2 (en) | Pharmaceutical compositions | |
| US20080044461A1 (en) | Transdermal methods and systems for treating Alzheimer's disease | |
| TWI621448B (zh) | 里曼提明(rivastigmine)經皮組成物及使用其之方法 | |
| JP6978417B2 (ja) | プラミペキソール経皮送達系及びその使用 | |
| MX2008006956A (es) | Sistema terapeutico transdermico | |
| HK1151740A (en) | Transdermal therapeutic system | |
| HK1153646B (en) | Transdermal therapeutic system for the administration of rivastigmine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20080730 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20091007 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20091007 |
|
| A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20120724 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20121012 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20130122 |
|
| RD03 | Notification of appointment of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7423 Effective date: 20140612 |
|
| RD04 | Notification of resignation of power of attorney |
Free format text: JAPANESE INTERMEDIATE CODE: A7424 Effective date: 20140613 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20140728 |
|
| A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20141224 |